Abstract:
Cefuroxim esters I(R1 = C1-4 primary or secondary alkyl; R2 = C1-6 primary of secondary alkyl) were prepd. by the reaction of cefuroxim K salf with R2CHBrO2CR1 and the acylation of III with (Z)-2-(fur-2-y1)-2-methoxyimino-acetic acid. Thus, 4.57g cefuroxim was stirred with 760mg K2CO3 and 25ml N,N-dimethylformamide followed by the addn. of AcOCH2Br to give (R and S)-1-acetoxyethyl(6R,7R)-3-carbamoyloxymethyl-7-≮(Z)-2-(fur-2-y1)-2-methoxyiminoacetamido≉ceph-3-em-4-carboxylated. I are useful as antibiotics and are more easily absorbed after oral administration than cefuroxim.
Abstract:
6-Acylaminopenicillanic acid antibiotics having > 98 % purity was prepd. Thus, 6-Aminopenicillanic acid was treated with a silating agent, R1R2NCOR3 [R1 = H 1-6C alkyl or aralkyl; R2 = tri(1-6C) alkylsylyl or triarylsylyl; R3 = 1-6C alkyl, aralkyl [or R1N=C(OR2)R3[R1 = 1-6C alkyl, aralkyl, tri(1-6C)alkyl sylyl, triarylsylyl and the silayted deriv. I [R4 = H, tri(1-6C) alkylsylyl, triarylsylyl; R5 = tri(1-6C)alkylsylyl, triarylsylyl reacted with an acid chloride or protected acid chloride decompositing the sylyl group to yield the 6-acylaminopenicillanic acid.
Abstract:
Non-toxic 7- acylamidoceph-3 em -4-carboxylic acid derivs. (I; R= thienyl, furyl, Ra=Rb=H, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, cyano) of syn-isomer or syn-and anti-mixt. contg. >90% syn-isomer were manufd. Acylation for I was carried out at -20-30≦̸C in the reactive media such as methylene chloride, dimethlformamide or acetonitril. I showed broad spectral action, esp. to gram-negative bacteria.
Abstract:
The specification describes a process for preparing 17 Alpha carboxylate or neutral phosphate or carbonate esters of 17 Alpha -21-dihydroxy-20-oxo steroids wherein a 21-carboxylate or neutral phosphate or carbonate ester of a 17 Alpha ,21-dihydroxy-20-oxosteroid is treated with a non-hydroxylic base in an anhydrous aprotic medium to remove a proton selectively from the 17 Alpha hydroxyl grouping, and the reaction mixture neutralised or acidified whereby the intermediate product is protonated. The base used in the process can be for example a carbanionoid e.g. alkali metal alkyl, or metal amide, e.g. alkali metal amide, base. The process is applicable to the preparation of a wide variety of 17-esters of the above-mentioned type. The process can also be used to prepare certain enol-aldehydes corresponding to the above-described 17-ester, a particular class of these enolaldehydes being described in the specification as novel compounds.
Abstract:
Steroids of the 5 Alpha -pregnane series possessing a 3 Alpha hydroxy group, a 10-hydrogen atom or methyl group, an 11-oxo group, a 17 Alpha -hydrogen atom, a 20-oxo group, and a group of the formula -XR at the 21-position wherein -XR represents -OCOR, -OCOOR, -CCOSR or -OCONHR and R represents (a) a solubilising group containing a basic nitrogen atom, (b) a nitrobenzyl group (c) a lower alkyl group (when X is not -OCO-) or (d) a halogenoalkyl group. The steroids possess anaesthetic properties.
Abstract:
A process for preparing a 7-aminocephalosporin from a 7 Beta acylamidocephalosporin by the imide halide technique in which the 4-carboxyl group of the 7 Beta -acylamido cephalosporin is first protected by reaction with a phosphorus trihalide, particularly phosphorus trichloride.
Abstract:
The invention relates to a process for the preparation of 7 Beta -acylamido-3-methylceph-3-em-4-carboxylic acid esters from 6 Beta -acylamido penicillanic acid 1-oxide esters in the presence of catalysts which are salts or complexes of acids with nitrogen bases having a pKb of not less than 4. The salts or complexes may be formed in situ.
Abstract:
WHERE R IS AMINO OR BLOCKED AMINO, X IS -S-, -SO(A OR B) OR -S2-, AND AR IS A CARBOCYCLE OR A HETEROCYCLE SUBSTITUTED BY AT LEAST ONE ELECTRON WITHDRAWING SUBSTITUENT IN CONJUGATION WITH THE EXOCYCLIC -CH=CHDOUBLE BOND,AND SALTS AND ESTERS ARE USEFUL CHROMOGENIC AGENTS FOR THE DETECTION OF B-LACTAMASE ACTIVITY. TEST REAGENTS CONTAINING SUCH COMPOUNDS ARE ALSO DISCLOSED.
Abstract:
3A - HYDROXY-$4-STEROIDS AND 3A-ESTERS THEREOF HAVING AN ACETYL GROUP IN THE B-CONFIGURATION AND A HYDROGEN ATOM IN THE A-CONFIGURATION AT THE 17-POSITION AND EITHER TWO HYDROGEN ATOMS OR A KETO GROUP AT THE 11-POSITION. THE DISCLOSED COMPOUNDS WITH CARRIERS OR EXCIPIENTS TO PROVIDE COMPOSITIONS HAVING MARKED ANAESTHETIC PROPERTIES.